imvanex
bavarian nordic a/s - virus de la vaccine modifié ankara - bavarian nordic (mva-bn) - smallpox vaccine; monkeypox virus - d'autres vaccins viraux, - active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in adults (see sections 4. 4 et 5. l'utilisation de ce vaccin doit être en conformité avec les recommandations officielles.
mvabea
janssen-cilag international n.v. - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - fièvre hémorragique À virus ebola - vaccins - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.
imvamune suspension
bavarian nordic as - virus modifié de la vaccine (ankara-bavarian nordic) - suspension - 50000000dict50 - virus modifié de la vaccine (ankara-bavarian nordic) 50000000dict50 - vaccines
jynneos suspension injectable
bavarian nordic switzerland ag - virus vaccinia ankara modificatus vivus attenuatum - suspension injectable - virus vaccinia ankara modificatus vivus attenuatum ≥ 50 mio. u., trometamolum, natrii chloridum corresp. natrium 1.6 mg, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml. - aktive immunisierung gegen durch pocken-, affenpocken- und vacciniaviren hervorgerufene erkrankungen - les vaccins
raboral v-rg sol. buv.
boehringer ingelheim animal health belgium sa-nv - glycoprotéine rabique, recombinant - solution buvable en sachet - virus rabique inactivé - live viral vaccines - autres ou inconnu
tecovirimat siga
siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antiviraux à usage systémique - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 et 5. tecovirimat siga should be used in accordance with official recommendations.
scheriproct pommade
medius ag - prednisoloni-21 hexanoas, cinchocaini hydrochloridum - pommade - prednisoloni-21 hexanoas 1,9 mg, cinchocaini hydrochloridum 5 mg, arom.: bergamottae aetheroleum, vanillinum et d'autres, excipiens ad pommade pour 1 g de la. - les hémorroïdes, superficielles, de fissures anales, proctite ulcéreuse - synthetika
scheriproct suppositoires
medius ag - prednisoloni-21 hexanoas, cinchocaini hydrochloridum - suppositoires - prednisoloni-21 hexanoas 1,3 mg, cinchocaini hydrochloridum 1 mg, excipiens pro suppositorio. - les hémorroïdes, les fissures anales, proctite ulcéreuse - synthetika
d-germ 5 liquide
les produits sanitaires lÉpine inc. - chlorure d'octyl décyl diméthyl ammonium; chlorure de dioctyl-diméthyl ammonium; chlorure de didécyl-diméthyl ammonium; chlorure de benzalkonium - liquide - 3.255%; 1.628%; 1.628%; 4.339% - chlorure d'octyl décyl diméthyl ammonium 3.255%; chlorure de dioctyl-diméthyl ammonium 1.628%; chlorure de didécyl-diméthyl ammonium 1.628%; chlorure de benzalkonium 4.339% - disinfectants (for agents used on object)